 |
 |
|
1 June 1997 | Volume 126 Issue 11 | Pages 858-865
Background: Hemorrhage from esophageal varices remains a substantial management problem. Endoscopic sclerotherapy was preferred for more than a decade, but fluoroscopically placed intrahepatic portosystemic stents have recently been used with increasing frequency.
Objective: To compare sclerotherapy with transjugular intrahepatic portosystemic shunt (TIPS) in patients with bleeding from esophageal varices.
Design: Randomized, controlled clinical trial.
Setting: Three teaching hospitals.
Patients: 49 adults hospitalized with acute variceal hemorrhage from November 1991 to December 1995: 25 assigned to sclerotherapy and 24 assigned to TIPS.
Intervention: Patients assigned to repeated sclerotherapy had the procedure weekly. In those assigned to TIPS, an expandable mesh stent was fluoroscopically placed between an intrahepatic portal vein and an adjacent hepatic vein.
Measurements: Pretreatment measures included demographic and laboratory data. Postrandomization data included index hospitalization survival, duration of follow-up, successful obliteration of varices, rebleeding from varices, number of variceal rebleeding events, total days of hospitalization for variceal bleeding, blood transfusion requirements after randomization, prevalence of encephalopathy, and total health care costs.
Results: Mean follow-up (± SE) was 567 ± 104 days in the sclerotherapy group and 575 ± 109 days in the TIPS group. Varices were obliterated more reliably by TIPS than by sclerotherapy (P < 0.001). Patients having TIPS were significantly less likely to rebleed from esophageal varices than patients receiving sclerotherapy (3 of 24 compared with 12 of 25; P = 0.012). No other follow-up measures differed significantly between groups. A trend toward improved survival, which was not statistically significant, was noted in the TIPS group (hazard ratio, 0.53 [95% CI, 0.18 to 1.5]).
Conclusions: In obliterating varices and reducing rebleeding events from esophageal varices, TIPS was more effective than sclerotherapy. However, TIPS did not decrease morbidity after randomization or improve health care costs. It seemed to produce better survival, but the increase in survival was not statistically significant.
ARTICLE
Endoscopic Sclerotherapy Compared with Percutaneous Transjugular Intrahepatic Portosystemic Shunt after Initial Sclerotherapy in Patients with Acute Variceal Hemorrhage
A Randomized, Controlled Trial
Related articles in Annals:
This article has been cited by other articles:
 |
|
 |
|
  P. Rossi, F. M. Salvatori, F. Fanelli, M. Bezzi, M. Rossi, G. Marcelli, D. Pepino, O. Riggio, and R. Passariello Polytetrafluoroethylene-covered Nitinol Stent-Graft for Transjugular Intrahepatic Portosystemic Shunt Creation: 3-year Experience Radiology, June 1, 2004; 231(3): 820 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Tripathi, H F Lui, A Helmy, K Dabos, E Forrest, A J Stanley, R Jalan, D N Redhead, and P C Hayes Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding Gut, March 1, 2004; 53(3): 431 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. McFadden Invited Commentary RadioGraphics, January 1, 2004; 24(1): 36 - 37. [Full Text] [PDF]
|
|
|
|
|
|
H. Kiyosue, H. Mori, S. Matsumoto, Y. Yamada, Y. Hori, and Y. Okino Transcatheter Obliteration of Gastric Varices: Part 2. Strategy and Techniques Based on Hemodynamic Features RadioGraphics, July 1, 2003; 23(4): 921 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. W. Zhuang, G. J. Teng, R. F. Jeffery, J. M. Gemery, B. J. d'Othee, and M. A. Bettmann Long-Term Results and Quality of Life in Patients Treated with Transjugular Intrahepatic Portosystemic Shunts Am. J. Roentgenol., December 1, 2002; 179(6): 1597 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A K BURROUGHS, D W PATCH, R JALAN, and P C HAYES Management of variceal haemorrhage in cirrhotic patients Reply Gut, May 1, 2001; 48(5): 738a - 740. [Full Text] [PDF]
|
|
|
|
|
|
G Pomier-Layrargues, J-P Villeneuve, M Deschenes, B Bui, P Perreault, D Fenyves, B Willems, D Marleau, M Bilodeau, M Lafortune, et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial Gut, March 1, 2001; 48(3): 390 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P J Gow and R W Chapman Modern management of oesophageal varices Postgrad. Med. J., February 1, 2001; 77(904): 75 - 81. [Abstract] [Full Text]
|
|
|
|
|
|
R Jalan and P C Hayes UK guidelines on the management of variceal haemorrhage in cirrhotic patients Gut, June 1, 2000; 46(90003): iii1 - 15. [Full Text] [PDF]
|
|
|
|
|
|
R JALAN, H F LUI, D N REDHEAD, and P C HAYES TIPSS 10 years on Gut, April 1, 2000; 46(4): 578 - 581. [Full Text] [PDF]
|
|
|
|
|
|
Z. J. Haskal Improved Patency of Transjugular Intrahepatic Portosystemic Shunts in Humans: Creation and Revision with PTFE Stent-Grafts Radiology, December 1, 1999; 213(3): 759 - 766. [Abstract] [Full Text]
|
|
|
|
|
|
A. Luca, G. D'Amico, R. La Galla, M. Midiri, A. Morabito, and L. Pagliaro TIPS for Prevention of Recurrent Bleeding in Patients with Cirrhosis: Meta-analysis of Randomized Clinical Trials Radiology, August 1, 1999; 212(2): 411 - 421. [Abstract] [Full Text]
|
|
|
|
 |
|
 ""TIPS"" OR SCLEROTHERAPY FOR ESOPHAGEAL VARICES? Journal Watch (General), June 17, 1997; 1997(617): 2 - 2. [Full Text]
|
|
|
|
|
|
M. Cejna, M. Peck-Radosavljevic, S. A. Thurnher, K. Hittmair, M. Schoder, and J. Lammer Creation of Transjugular Intrahepatic Portosystemic Shunts with Stent-Grafts: Initial Experiences with a Polytetrafluoroethylene-covered Nitinol Endoprosthesis Radiology, November 1, 2001; 221(2): 437 - 446. [Abstract] [Full Text] [PDF]
|
|
Article
